Cannabis Report across cannabis plants
(Source: File image)
Curaleaf to acquire Aurora Cannabis. (Source: Google Gemini. Generated by AI)

Curaleaf (TSX:CURA) intends to make a takeover bid for Aurora Cannabis (TSX/NASDAQ:ACB) at $4 per share, representing a 45 per cent premium to the company’s 30-day volume-weighted average price, which would make the resulting entity one of the largest and most diversified cannabis companies in the world.

Click here for the full story.

Top cannabis news stories

1 | Canopy Growth radically reduces losses in Q1 FY2027

2 | Cannabis microcap MediPharm Q2 results reports revenue up by 11 per cent quarter-over-quarter

3 | Auxly reports 18 per cent revenue increase in Q2 2026 results

4 | Rubicon reports Q2 2026 revenue of $18.5 million, up 35 per cent sequentially and 23 per cent year-over-year

Top Cannabis Stocks Aug. 07 to Aug. 13, 2026

1. T.LABS | 4,554 views | Medipharm Labs Corp.
2. T.CURA | 3,350 views | Curaleaf Holdings Inc.
3. T.TLRY | 2,545 views | Tilray Brands Inc.
4.T.OGI | 418 views | Organigram Global Inc.
5. C.TGIF | 364 views | 1933 Industries Inc.
6. C.BLO| 256 views | Cannabix Technologies Inc.


Join the discussion: Find out what investors are saying about cannabis stocks and make sure to explore the rest of Stockhouse’s stock forums and message boards.


More From The Market Online

Cannabis microcap posts potent Q2 results

MediPharm Labs (TSX:LABS), a cannabis-focused pharma company, elevated into positive net income in Q2 2026.

Curaleaf lights up cannabis market with Aurora takeover bid

Curaleaf intends to take over Aurora Cannabis at US$4 per share, which would make it one of the largest cannabis companies in the world. 
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Pumpkins, profits & punches

Cannabix (CSE:BLO) will present its Marijuana Breath Test technology at the ABC 38th Annual Conference, a...

Canopy Growth radically reduces losses in Q1 FY2027

Canopy Growth added efficiency in Q1 FY2027, growing revenue and adjusted gross margins, while reducing adjusted EBITDA and net losses.